Thrombodynamics-A new global hemostasis assay for heparin monitoring in patients under the anticoagulant treatment.

Anna N BalandinaIlya I SerebriyskiyAlexander V PoletaevDmitry M PolokhovMarina A GrachevaEkaterina M KoltsovaDavid M VardanyanIrina A TaranenkoAlexey Yu KrylovEvdokiya S UrnovaKirill V LobastovArtem V ChernyakovElena M ShulutkoAndrey P MomotAlexander M ShulutkoFazoil I Ataullakhanov

Published in: PloS one (2018)

These results indicate that TD has a high sensitivity to the effects of UFH and LMWH after both prophylactic and therapeutic regimes and may be used for heparin monitoring.

Keyphrases

venous thromboembolism
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
high throughput
peritoneal dialysis
patient reported outcomes
single cell
smoking cessation